Abstract 285 Table 1
EndpointsHeart Transplant Control (n=523)Nodular Liver without Cirrhosis (n=24)P-value
3-Year Survival 85.1% 95.8% 0.148
3-Year Freedom from CAV 91.0% 95.8% 0.347
3-Year Freedom from NF-MACE 82.4% 91.7% 0.240
1-Year Freedom from ACR 94.1% 91.7% 0.669
1-Year Freedom from AMR 95.0% 91.7% 0.479